Clinical trial
Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy
NCT05122065 is registered in ClinicalTrials.gov with FemTec Health Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy
- Lead sponsor
- FemTec Health Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- December 15, 2022
- Enrollment
- 432 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
genitourinary syndrome of menopause, hormone replacement therapy, menopause